262 related articles for article (PubMed ID: 24859761)
1. Generation and characterization of nanobodies against rhGH expressed as sfGFP fusion protein.
Abbady AQ; Al-Shemali R; Mir Assaad J; Murad H
Gen Comp Endocrinol; 2014 Aug; 204():33-42. PubMed ID: 24859761
[TBL] [Abstract][Full Text] [Related]
2. Characterization of camel nanobodies specific for superfolder GFP fusion proteins.
Twair A; Al-Okla S; Zarkawi M; Abbady AQ
Mol Biol Rep; 2014 Oct; 41(10):6887-98. PubMed ID: 25085037
[TBL] [Abstract][Full Text] [Related]
3. Exploiting Nanobodies in the Detection and Quantification of Human Growth Hormone
Murad H; Assaad JM; Al-Shemali R; Abbady AQ
Front Endocrinol (Lausanne); 2017; 8():115. PubMed ID: 28611730
[TBL] [Abstract][Full Text] [Related]
4. Characterization and applications of Nanobodies against human procalcitonin selected from a novel naïve Nanobody phage display library.
Yan J; Wang P; Zhu M; Li G; Romão E; Xiong S; Wan Y
J Nanobiotechnology; 2015 May; 13():33. PubMed ID: 25944262
[TBL] [Abstract][Full Text] [Related]
5. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
[TBL] [Abstract][Full Text] [Related]
6. Prokaryotic overexpression of TEV-rhGH and characterization of its polyclonal antibody.
Murad H; Ali B; Makeya R; Abbady AQ
Gene; 2014 May; 542(1):69-76. PubMed ID: 24534464
[TBL] [Abstract][Full Text] [Related]
7. Selection and Characterization of Specific Nanobody Against Human Immunoglobulin G.
Kazemi-Lomedasht F; Behdani M; Rahimpour A; Habibi-Anbouhi M; Poshang-Bagheri K; Shahbazzadeh D
Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):201-5. PubMed ID: 26090598
[TBL] [Abstract][Full Text] [Related]
8. [Preparation and identification of anti-follicle-stimulating hormone receptor nanobodies].
Xia X; M M; Zhai T; Li J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):829-33. PubMed ID: 23948408
[TBL] [Abstract][Full Text] [Related]
9. Soluble expression of single-chain variable fragment (scFv) in Escherichia coli using superfolder green fluorescent protein as fusion partner.
Liu M; Wang B; Wang F; Yang Z; Gao D; Zhang C; Ma L; Yu X
Appl Microbiol Biotechnol; 2019 Aug; 103(15):6071-6079. PubMed ID: 31175428
[TBL] [Abstract][Full Text] [Related]
10. Development and production of nanobodies specifically against green fluorescence protein.
Fang Z; Cao D; Qiu J
Appl Microbiol Biotechnol; 2020 Jun; 104(11):4837-4848. PubMed ID: 32270250
[TBL] [Abstract][Full Text] [Related]
11. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
[TBL] [Abstract][Full Text] [Related]
12. Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.
Liu B; Yang D
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163405
[TBL] [Abstract][Full Text] [Related]
13. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.
Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W
Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583
[TBL] [Abstract][Full Text] [Related]
14. Fenobody and RANbody-based sandwich enzyme-linked immunosorbent assay to detect Newcastle disease virus.
Ji P; Zhu J; Li X; Fan W; Liu Q; Wang K; Zhao J; Sun Y; Liu B; Zhou EM; Zhao Q
J Nanobiotechnology; 2020 Mar; 18(1):44. PubMed ID: 32169061
[TBL] [Abstract][Full Text] [Related]
15. Microcystin-LR nanobody screening from an alpaca phage display nanobody library and its expression and application.
Xu C; Yang Y; Liu L; Li J; Liu X; Zhang X; Liu Y; Zhang C; Liu X
Ecotoxicol Environ Saf; 2018 Apr; 151():220-227. PubMed ID: 29353171
[TBL] [Abstract][Full Text] [Related]
16. Bactrian camel nanobody-based immunoassay for specific and sensitive detection of Cry1Fa toxin.
Wang P; Li G; Yan J; Hu Y; Zhang C; Liu X; Wan Y
Toxicon; 2014 Dec; 92():186-92. PubMed ID: 25448390
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody.
Kazemi-Lomedasht F; Behdani M; Bagheri KP; Habibi-Anbouhi M; Abolhassani M; Arezumand R; Shahbazzadeh D; Mirzahoseini H
Mol Immunol; 2015 May; 65(1):58-67. PubMed ID: 25645505
[TBL] [Abstract][Full Text] [Related]
18. Generation of mWasabi fluorescent protein-binding nanobodies.
Li S; Shan H; Wang T; Zheng X; Shi M; Chen B; Lu H; Zhang Y; Zhao S; Hua Z
Anal Biochem; 2020 Nov; 608():113875. PubMed ID: 32739350
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a nanobody phage display library constructed from a Brucella-immunised camel.
Abbady AQ; Al-Mariri A; Zarkawi M; Al-Assad A; Muyldermans S
Vet Immunol Immunopathol; 2011 Jul; 142(1-2):49-56. PubMed ID: 21592585
[TBL] [Abstract][Full Text] [Related]
20. Construction of a synthetic phage-displayed Nanobody library with CDR3 regions randomized by trinucleotide cassettes for diagnostic applications.
Yan J; Li G; Hu Y; Ou W; Wan Y
J Transl Med; 2014 Dec; 12():343. PubMed ID: 25496223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
